Many Organizations Launch Their Precision Medicine Initiatives With Pharmacogenomics. Why?
18% Of 4 Billion Prescriptions In The US Affected By Actionable Pharmacogenomics2
34% of adverse drug reactions caused by Drug-Gene interactions (rather than Drug-Drug interactions)3
Better Decisions, Better Results
We enable healthcare organizations to get started with precision medicine anywhere they want – oncology? pediatrics? cardiology? pharmacogenomics?